Literature DB >> 23404306

Selenoprotein S expression in the rat brain following focal cerebral ischemia.

Li Xia Liu1, Xue Ying Zhou, Cheng Shan Li, Li Qing Liu, Shan Ying Huang, Sheng Nian Zhou.   

Abstract

Recent studies on cerebral ischemic stroke have demonstrated the importance of the inflammatory response. Ongoing inflammatory insults have been implicated as a secondary mechanism underlying neuronal injury induced by ischemia, and anti-inflammatory strategies have gained considerable interest. Selenoprotein S (SelS), which is an endoplasmic reticulum resident protein, is known to promote cell survival by regulating inflammation. Moreover, SelS has been shown to be responsive to ischemia in cultured astrocytes. A Finnish report revealed that a variation in the SelS gene locus is associated with a higher predisposition to ischemic stroke in humans, suggesting a crucial role for SelS in protection against brain ischemia. However, the time-course of SelS expression following cerebral ischemia in vivo remains unknown. In the present study, we show, for the first time, differential SelS expression from 3 h to 7 days after reperfusion in rats with transient focal cerebral ischemia induced by a 1-h middle cerebral artery occlusion. We found that the SelS protein level decreased in the ischemic core 3-7 days after reperfusion. Furthermore, SelS expression was upregulated in the ischemic penumbra adjacent to the ischemic core 3-7 days after reperfusion and is matched by reactive astrogliosis. Thus, we propose that the upregulation of Sels represents a reaction of astrocytes against inflammatory stimuli, and the findings of this study open a new chapter in the research of the interrelationships between SelS and cerebral ischemic stroke.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23404306     DOI: 10.1007/s10072-013-1319-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  24 in total

Review 1.  The inflammatory response in stroke.

Authors:  Qing Wang; Xian Nan Tang; Midori A Yenari
Journal:  J Neuroimmunol       Date:  2006-12-26       Impact factor: 3.478

2.  Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model.

Authors:  S A Menzies; J T Hoff; A L Betz
Journal:  Neurosurgery       Date:  1992-07       Impact factor: 4.654

3.  Genetic variation in selenoprotein S influences inflammatory response.

Authors:  Joanne E Curran; Jeremy B M Jowett; Kate S Elliott; Yuan Gao; Kristi Gluschenko; Jianmin Wang; Dalia M Abel Azim; Guowen Cai; Michael C Mahaney; Anthony G Comuzzie; Thomas D Dyer; Ken R Walder; Paul Zimmet; Jean W MacCluer; Greg R Collier; Ahmed H Kissebah; John Blangero
Journal:  Nat Genet       Date:  2005-10-09       Impact factor: 38.330

4.  C-reactive protein is a determinant of first-ever stroke: prospective nested case-referent study.

Authors:  Jonas Andersson; Lars Johansson; Per Ladenvall; Per-Gunnar Wiklund; Birgitta Stegmayr; Christina Jern; Kurt Boman
Journal:  Cerebrovasc Dis       Date:  2009-04-24       Impact factor: 2.762

Review 5.  Inflammation as a therapeutic target in acute ischemic stroke treatment.

Authors:  Antonino Tuttolomondo; Riccardo Di Sciacca; Domenico Di Raimondo; Chiara Renda; Antonio Pinto; Giuseppe Licata
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

Review 6.  Inflammation in ischemic brain injury: timing is important.

Authors:  Jasna Kriz
Journal:  Crit Rev Neurobiol       Date:  2006

7.  SEPS1 gene is activated during astrocyte ischemia and shows prominent antiapoptotic effects.

Authors:  Noelia Fradejas; María Dolores Pastor; Silvia Mora-Lee; Pedro Tranque; Soledad Calvo
Journal:  J Mol Neurosci       Date:  2008-05-23       Impact factor: 3.444

8.  Reversible middle cerebral artery occlusion without craniectomy in rats.

Authors:  E Z Longa; P R Weinstein; S Carlson; R Cummins
Journal:  Stroke       Date:  1989-01       Impact factor: 7.914

Review 9.  Ischemic stroke intervention requires mixed cellular protection of the penumbra.

Authors:  Frank C Barone
Journal:  Curr Opin Investig Drugs       Date:  2009-03

10.  A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients.

Authors:  H C A Emsley; C J Smith; R F Georgiou; A Vail; S J Hopkins; N J Rothwell; P J Tyrrell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-10       Impact factor: 10.154

View more
  5 in total

1.  Polymorphisms in inflammatory and immune response genes associated with cerebral cavernous malformation type 1 severity.

Authors:  Hélène Choquet; Ludmila Pawlikowska; Jeffrey Nelson; Charles E McCulloch; Amy Akers; Beth Baca; Yasir Khan; Blaine Hart; Leslie Morrison; Helen Kim
Journal:  Cerebrovasc Dis       Date:  2014-12-03       Impact factor: 2.762

2.  Pharmacological Inhibition of PERK Attenuates Early Brain Injury After Subarachnoid Hemorrhage in Rats Through the Activation of Akt.

Authors:  Feng Yan; Shenglong Cao; Jianru Li; Brandon Dixon; Xiaobo Yu; Jingyin Chen; Chi Gu; Wang Lin; Gao Chen
Journal:  Mol Neurobiol       Date:  2016-02-18       Impact factor: 5.590

Review 3.  Selenoprotein S: a therapeutic target for diabetes and macroangiopathy?

Authors:  Shan-Shan Yu; Jian-Ling Du
Journal:  Cardiovasc Diabetol       Date:  2017-08-10       Impact factor: 9.951

4.  Features of the cytoprotective effect of selenium nanoparticles on primary cortical neurons and astrocytes during oxygen-glucose deprivation and reoxygenation.

Authors:  E A Turovsky; V N Mal'tseva; R M Sarimov; A V Simakin; S V Gudkov; E Y Plotnikov
Journal:  Sci Rep       Date:  2022-02-02       Impact factor: 4.996

Review 5.  How cytosolic compartments play safeguard functions against neuroinflammation and cell death in cerebral ischemia.

Authors:  Fari Ryan; Seyed Esmaeil Khoshnam; Fariba Khodagholi; Ghorbangol Ashabi; Abolhassan Ahmadiani
Journal:  Metab Brain Dis       Date:  2021-06-26       Impact factor: 3.584

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.